FY2025 · period end Dec '25 · from the 10-K filed Feb 23, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $20.38B | $20.10B | $19.46B | $17.97B | $17.42B |
| Gross Profit | $12.25B | $12.16B | $11.33B | $10.25B | $10.38B |
| Operating Income | $3.31B | $4.27B | $3.98B | $2.89B | $3.33B |
| Net Income | $2.13B | $2.89B | $2.30B | $1.78B | $2.17B |
| EPS (Diluted) | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $16.33B | $16.05B | $16.39B | $15.73B | $15.04B |
| Total Liabilities | $15.96B | $15.50B | $15.44B | $14.93B | $14.07B |
| Stockholders' Equity | $0.36B | $0.54B | $0.96B | $0.81B | $0.97B |
| Cash & Equivalents | $1.29B | $1.10B | $0.97B | $0.78B | $0.83B |
| Total Debt | $7.99B | $7.94B | $8.24B | $8.76B | $7.21B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.20B | $4.11B | $3.75B | $2.56B | $3.33B |
| Capital Expenditures | — | — | — | $0.70B | $0.57B |
| Free Cash Flow | — | — | — | $1.86B | $2.76B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 60.1% | 60.5% | 58.2% | 57.0% | 59.6% |
| Operating Margin | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Return on Equity | 469.1% | 384.9% | 260.9% | 200.9% | 209.1% |
| Return on Assets | 13.2% | 17.8% | 14.3% | 11.6% | 14.0% |
| Debt / Equity | 21.88× | 14.60× | 8.61× | 10.86× | 7.42× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0000021665-26-000042 | Jun 30, 2026 | Jul 31, 2026 | Jul 31, 2026 12:32 UTC | EDGAR |
| 8-K | 0000021665-26-000041 | Jul 31, 2026 | Jul 31, 2026 | Jul 31, 2026 11:58 UTC | EDGAR |
| 8-K | 0000021665-26-000025 | May 8, 2026 | May 13, 2026 | May 13, 2026 20:02 UTC | EDGAR |
| 10-Q | 0000021665-26-000023 | Mar 31, 2026 | May 1, 2026 | May 1, 2026 12:16 UTC | EDGAR |
| 8-K | 0000021665-26-000022 | Apr 30, 2026 | May 1, 2026 | May 1, 2026 11:31 UTC | EDGAR |
| 8-K | 0000021665-26-000015 | Apr 8, 2026 | Apr 9, 2026 | Apr 9, 2026 12:22 UTC | EDGAR |
| 8-K | 0000021665-26-000010 | Mar 17, 2026 | Mar 17, 2026 | Mar 17, 2026 20:33 UTC | EDGAR |
| 8-K | 0000021665-26-000008 | Mar 12, 2026 | Mar 12, 2026 | Mar 12, 2026 20:33 UTC | EDGAR |
Direct links to SEC EDGAR. CL has additional filings available on the SEC site.
6 numbers COLGATE PALMOLIVE CO later changed — same XBRL tag, both filings linked.
Operating Income (Loss)·FY 2017
Notable restatementwas$3.6B
Revised up in a 10-K.
Operating Income (Loss)·Q3 2017
Notable restatementwas$927M
Revised up in a 10-Q.
Operating Income (Loss)·FY 2016
Notable restatementwas$3.8B
Revised up in a 10-K.
Operating Income (Loss)·Q1 2017
Notable restatementwas$885M
Revised up in a 10-Q.
Operating Income (Loss)·Q2 2017
Notable restatementwas$853M
Revised up in a 10-Q.
Liabilities·As of Dec 31, 2013
Minor restatementwas$11.3B
Revised up in a 10-K.
CL is not the only one.
See every restatement we've found across the market — or get an alert the next time CL revises a number.
Restatements are detected by comparing every vintage of a fact across all of COLGATE PALMOLIVE CO's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CL's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling COLGATE PALMOLIVE CO — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on CL yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on CL and publish the result to your public profile.
Ask about COLGATE PALMOLIVE CO
Continue in Workspace — cited answers on CL, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs